Engineering Next Generation mRNA-Based Therapeutic Proteins to Advance Infectious & Rare Disease Therapy Portfolios

11:00 am - Tuesday 21st July 2026

  • Providing an overview of the mRNA platform
  • Case Study Presentation: mRNA encoded IgGs/VHHs for the treatment of infectious diseases
  • Case Study Presentation: Engineering next generation cas9 proteins to advance rare disease therapies

Speakers:

Director (<i>In Vivo </i>Expressed Biologics - mRNA)
AstraZeneca